Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 8/20 | 0.36 |
| ▸ | ACACA | Q13085 | 5/20 | 0.36 |
| ▸ | DRD2 | P14416 | 2/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CASP1 | P29466 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | CASP7 | P55210 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | HTR4 | Q13639 | 1/20 | 0.34 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29960814 | 0.93 | ACACB (0.39) | ACACBACACADRD2HPGDKDM4E | |
| Hydrochloric Acid SCHEMBL29960746 | 0.76 | TAAR1 (0.44) | DRD2 | |
| SCHEMBL29960757 | 0.75 | ACACB (0.39) | ACACBACACADRD2EPHX1HPGD | |
| SCHEMBL29960238 | 0.72 | DRD2 (0.39) | ACACBACACADRD2KDM4E | |
| SCHEMBL29960335 | 0.72 | ACACB (0.44) | ACACBACACADRD2 | |
| SCHEMBL29960785 | 0.72 | P2RX7 (0.45) | ACACBACACA | |
| SCHEMBL14906835 | 0.72 | DRD2 (0.42) | ACACBACACADRD2EPHX1LMNA | |
| SCHEMBL29960245 | 0.70 | BRD4 (0.41) | ACACBDRD2LMNA | |
| SCHEMBL29960433 | 0.70 | TAAR1 (0.41) | — | |
| SCHEMBL17361826 | 0.69 | KDM4C (0.51) | ACACB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022204150-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS | BLUE OAK PHARMACEUTICALS, INC. (US) | 2022-09-29 | — | — | WO | disclosed |